Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study
Aims: whether the plasma-based ceramide-based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain.
Materials and methods: baseline and follow-up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54–79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0). Based on the CERT1 risk score, patients were split into four risk categories (low, moderate, increased or high risk). The primary outcome was a composite of overall mortality and incident nonfatal CVD outcomes (including myocardial infarction, ischaemic stroke or permanent atrial fibrillation).
Results: one hundred and thirty-nine patients developed the primary composite outcome (72 nonfatal CVD outcomes and 67 total deaths) during follow-up. Baseline CERT1 risk categories were significantly associated with the risk of developing the primary composite outcome (adjusted HR for high vs. low-risk category 2.43, 95% CI 1.39–4.22, p = 0.002, and adjusted HR for increased vs. low-risk category 2.16, 95% CI 1.28–3.63, p = 0.004). Receiver operator characteristic curve analysis showed that adding CERT1 risk score to traditional CVD risk factors and pre-existing CVD, improved the discriminatory capability of the regression model for predicting the primary composite outcome (AUROC 0.691 [95% CI 0.674–0.769] vs. 0.722 [95% CI 0.642–0.742], p = 0.0275).
Conclusions the ceramide-based risk score CERT1 risk score improves risk prediction for long-term risk of overall mortality and adverse cardiovascular outcomes in patients with and without CVD.
CERT1 score, CVD, cardiovascular morbidity, mortality, plasma ceramides
1488-1497
Mantovani, Alessandro
14094518-4dce-4b10-91af-8fa4e362e987
Lunardi, Gianluigi
50f8731b-769b-47a8-aa67-311b47fd708c
Bonapace, Stefano
8510ed9a-bcb9-4c2b-8c4c-7a4181c0e28d
Molinero, Agustin E.
0ac25baf-b8f8-4992-8072-0f5ce5f2f4d0
Morandin, Riccardo
9a4802e6-c8a8-43de-a18a-52227094db89
Fiorio, Veronica
da165672-fa18-42da-bde4-387026568ea6
Molon, Giulio
3533be73-8d90-4ac3-9d95-4ece41678d29
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
404b0f39-7235-42b3-a296-6ef8fb4c9d3a
1 March 2025
Mantovani, Alessandro
14094518-4dce-4b10-91af-8fa4e362e987
Lunardi, Gianluigi
50f8731b-769b-47a8-aa67-311b47fd708c
Bonapace, Stefano
8510ed9a-bcb9-4c2b-8c4c-7a4181c0e28d
Molinero, Agustin E.
0ac25baf-b8f8-4992-8072-0f5ce5f2f4d0
Morandin, Riccardo
9a4802e6-c8a8-43de-a18a-52227094db89
Fiorio, Veronica
da165672-fa18-42da-bde4-387026568ea6
Molon, Giulio
3533be73-8d90-4ac3-9d95-4ece41678d29
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
404b0f39-7235-42b3-a296-6ef8fb4c9d3a
Mantovani, Alessandro, Lunardi, Gianluigi, Bonapace, Stefano, Molinero, Agustin E., Morandin, Riccardo, Fiorio, Veronica, Molon, Giulio, Byrne, Chrisopher D. and Targher, Giovanni
(2025)
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study.
Diabetes, Obesity and Metabolism, 27 (3), .
(doi:10.1111/dom.16156).
Abstract
Aims: whether the plasma-based ceramide-based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain.
Materials and methods: baseline and follow-up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54–79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0). Based on the CERT1 risk score, patients were split into four risk categories (low, moderate, increased or high risk). The primary outcome was a composite of overall mortality and incident nonfatal CVD outcomes (including myocardial infarction, ischaemic stroke or permanent atrial fibrillation).
Results: one hundred and thirty-nine patients developed the primary composite outcome (72 nonfatal CVD outcomes and 67 total deaths) during follow-up. Baseline CERT1 risk categories were significantly associated with the risk of developing the primary composite outcome (adjusted HR for high vs. low-risk category 2.43, 95% CI 1.39–4.22, p = 0.002, and adjusted HR for increased vs. low-risk category 2.16, 95% CI 1.28–3.63, p = 0.004). Receiver operator characteristic curve analysis showed that adding CERT1 risk score to traditional CVD risk factors and pre-existing CVD, improved the discriminatory capability of the regression model for predicting the primary composite outcome (AUROC 0.691 [95% CI 0.674–0.769] vs. 0.722 [95% CI 0.642–0.742], p = 0.0275).
Conclusions the ceramide-based risk score CERT1 risk score improves risk prediction for long-term risk of overall mortality and adverse cardiovascular outcomes in patients with and without CVD.
Text
cert1 score and outcomes_R1_clean copy
- Accepted Manuscript
Text
Figure 1
- Accepted Manuscript
Text
Figure 2
- Accepted Manuscript
Text
Figure 3
- Accepted Manuscript
Restricted to Repository staff only until 14 December 2025.
Request a copy
Text
Online-only Supplementary Material_R1
- Accepted Manuscript
Restricted to Repository staff only until 14 December 2025.
Request a copy
Text
Diabetes Obesity Metabolism - 2024 - Mantovani - Ceramide‐based risk score CERT‐1 improves risk prediction for overall
- Version of Record
Show all 6 downloads.
More information
Accepted/In Press date: 14 December 2024
e-pub ahead of print date: 26 December 2024
Published date: 1 March 2025
Keywords:
CERT1 score, CVD, cardiovascular morbidity, mortality, plasma ceramides
Identifiers
Local EPrints ID: 497341
URI: http://eprints.soton.ac.uk/id/eprint/497341
ISSN: 1462-8902
PURE UUID: 0ce1890c-c87c-4cc2-b605-e989edd6a6e0
Catalogue record
Date deposited: 20 Jan 2025 17:53
Last modified: 22 Aug 2025 01:45
Export record
Altmetrics
Contributors
Author:
Alessandro Mantovani
Author:
Gianluigi Lunardi
Author:
Stefano Bonapace
Author:
Agustin E. Molinero
Author:
Riccardo Morandin
Author:
Veronica Fiorio
Author:
Giulio Molon
Author:
Giovanni Targher
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics